FIELD: organic chemistry, antibiotics. SUBSTANCE: invention relates to new (7R)-7-acylamino-3-heteroarylthio-3-cephem carboxylic acid of the formula: or its pharmaceutically acceptable salts wherein R1 is taken among group consisting of optionally substituted thiazole and optionally substituted thiadiazole; R3 represents substituted pyridyl, and also to compound of the formula: or its pharmaceutically acceptable salt wherein R′2 is taken among group consisting of: -C(O)-R88,-C(O)-OR89,-C(O)-CH(NHR′3)-alk4 and wherein R88 represents or ; R′3 is taken among group consisting of hydrogen atom, alkyl and -C(O)-CH(NH2)-alk4 wherein alk4 is taken among group consisting of hydrogen atom and alkyl optionally substituted with one or more substituents taken among group consisting of -COOH, -C(O) -OR89, -C(O)NH2, - OH, -NH2/ and wherein R89 is taken among group consisting of benzhydryl, tert.-butyl, allyl, p- nitrobenzyl, benzyl, p- or o-nitrobenzyl, 2,2,2-trichloroethyl, cinnamide, 2-chloroallyl, tert. -amyl, trityl, 4- methoxytrityl, 4,4'-dimethoxytrityl, trimethylsilyl, tert.-butyldimethylsilyl, β-(trimethylsilyl)-ethyl, 4- or 2- methoxybenzyl, 2,4-dimethoxybenzyl, 3,4-dimethoxybenzyl, 2,4,6-trimethoxybenzyl, methoxymethyl and 3,3-dimethylallyl. Invention relates also to an antibacterial composition used for treatment of methicillin- resistant staphylococcus bacterial infection comprising therapeutically effective dose of (7R)-7-acylamino-3- heteroarylthio-3-cephem-4-carboxylic acid or it salt in pharmaceutically acceptable carrier. Invention provides preparing new compounds that exhibit antibiotic activity with regards to broad order of organisms including organisms resistant to β-lactam antibiotics. EFFECT: valuable medicinal properties of compounds. 17 cl, 2 tbl, 140 ex
Authors
Dates
2004-03-20—Published
2000-09-21—Filed